Royalty payments and Canada's Access to Medicines Regime
A pharmaceutical company that holds a compulsory licence under Canada's Access to Medicines Regime is required to pay royalties to the patent holder. The company must make payments within a prescribed amount of time and in accordance with a prescribed formula.
- Publisher - Current Organization Name: Health Canada
- Licence: Open Government Licence - Canada
Data and Resources
-
Royalty payments and Canada's Access to Medicines RegimeHTMLEnglish publication HTML
-
Royalty payments and Canada's Access to Medicines RegimeHTMLFrench publication HTML
Similar records